Stock Market

Cipla receives EIR Report from USFDA for Indore facility

Like this story, share it with millions of investors on M3





Cipla receives EIR Report from USFDA for Indore facility


Drug major Cipla today said it has received Establishment Inspection Report from the US health regulator for its Indore plant after completion of the inspection there.